Disc Medicine (IRON) Profit After Tax (2020 - 2026)

Disc Medicine (IRON) has reported Profit After Tax for 7 consecutive years, with -$59.5 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Profit After Tax fell 7.76% year-over-year to -$59.5 million; the TTM figure through Jun 2026 stood at -$245.9 million (down 69.13% YoY), while the FY2025 annual figure was -$212.2 million, down 94.03% from the prior year.
• Profit After Tax advanced to -$59.5 million in Q2 2026 per IRON's latest filing, from -$63.5 million in the prior quarter.
• Across five years, Profit After Tax topped out at -$9.6 million in Q2 2022 and bottomed at -$63.5 million in Q1 2026.
• Historically, Profit After Tax has averaged -$31.5 million across 5 years, with a median of -$26.5 million in 2024.
• On a YoY basis, Profit After Tax climbed as much as 48.27% in 2022 and fell as far as 162.2% in 2022.
• Disc Medicine's Profit After Tax stood at -$11.2 million in 2022, then plunged by 109.7% to -$23.6 million in 2023, then dropped by 24.93% to -$29.5 million in 2024, then sank by 105.49% to -$60.5 million in 2025, then gained by 1.65% to -$59.5 million in 2026.
• Business Quant data shows IRON's Profit After Tax at -$59.5 million in Q2 2026, -$63.5 million in Q1 2026, and -$60.5 million in Q4 2025.